{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:31:06Z","timestamp":1774625466236,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13104-019-4398-6","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T16:03:09Z","timestamp":1561996989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi"],"prefix":"10.1186","volume":"12","author":[{"given":"Ibrahim","family":"Chikowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"McDonald","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasco","family":"Mwakaswaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shagufta","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitsanzo","family":"Mafuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Kampira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"issue":"1","key":"4398_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2009.11.1\/krmerikangas","volume":"11","author":"KR Merikangas","year":"2009","unstructured":"Merikangas KR, Nakamura EF, Kessler RC. Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci. 2009;11(1):7\u201320.","journal-title":"Dialogues Clin Neurosci"},{"key":"4398_CR2","doi-asserted-by":"publisher","DOI":"10.30875\/c5be4728-en","volume-title":"World health report 2013","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. World health report 2013. Geneva: WHO; 2013."},{"key":"4398_CR3","unstructured":"World Health Organisation. Adolescent mental health. 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/adolescent-mental-health . Accessed 10 May 2019."},{"issue":"5","key":"4398_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/0020764013495527","volume":"60","author":"M Udedi","year":"2013","unstructured":"Udedi M, et al. Health service utilization by patients with common mental disorder identified by the Self-reporting Questionnaire in a primary care setting in Zomba, Malawi: a descriptive study. Int J Soc Psychiatry. 2013;60(5):454\u201361.","journal-title":"Int J Soc Psychiatry"},{"issue":"03","key":"4398_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1017\/S0033291713001141","volume":"44","author":"F Kauye","year":"2014","unstructured":"Kauye F, Jenkins R, Rahman A. Training primary health care workers in mental health and its impact on diagnoses of common mental disorders in primary care of a developing country, Malawi: a cluster-randomized controlled trial. Psychol Med. 2014;44(03):657\u201366.","journal-title":"Psychol Med"},{"issue":"l1","key":"4398_CR6","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.4103\/0976-500X.120957","volume":"4","author":"J Sultana","year":"2013","unstructured":"Sultana J, Cutroneo P, Trifir\u00f2 G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(l1):S73\u20137. https:\/\/doi.org\/10.4103\/0976-500X.120957 .","journal-title":"J Pharmacol Pharmacother"},{"key":"4398_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s40264-016-0422-0","volume":"39","author":"L Rolfes","year":"2016","unstructured":"Rolfes L, van Hunsel F, Taxis K, van Puijenbroek E. The impact of experiencing adverse drug reactions on the patient\u2019s quality of life: a retrospective cross-sectional study in the Netherlands. Drug Saf. 2016;39:769\u201376. https:\/\/doi.org\/10.1007\/s40264-016-0422-0 .","journal-title":"Drug Saf"},{"key":"4398_CR8","first-page":"101","volume":"8","author":"P Kurmi","year":"2015","unstructured":"Kurmi P, Paul PK, Dutta SK, Das S. To study the pattern of adverse drug reaction of antipsychotic drugs in a tertiary care hospital of Assam. Int J PharmTech Res. 2015;8:101\u20135.","journal-title":"Int J PharmTech Res"},{"issue":"1","key":"4398_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5530\/ijpcs.5.1.3","volume":"5","author":"A Afkat","year":"2016","unstructured":"Afkat A, Arshad H, Samina F, Shagufta P, Vineeta S, Zubair A. Prevalence and severity of adverse drug reactions (ADRs) in patients subjected to different anti-psychotic drugs in an out-patient Department of a Psychiatry Hospital in Kashmir; a prospective observational study. Int J Pharmacol Clin Sci. 2016;5(1):12\u20136.","journal-title":"Int J Pharmacol Clin Sci"},{"issue":"2","key":"4398_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/0253-7176.92067","volume":"33","author":"KG Piparva","year":"2011","unstructured":"Piparva KG, Buch JG, Chandrani KV. Analysis of adverse drug reactions of atypical antipsychotic drugs in psychiatry OPD. Indian J Psychol Med. 2011;33(2):153\u20137. https:\/\/doi.org\/10.4103\/0253-7176.92067 .","journal-title":"Indian J Psychol Med"},{"key":"4398_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/2348-9995.161377","volume":"2","author":"NS Kate","year":"2015","unstructured":"Kate NS, Pawar SS, Parkar SR, Sawant NS. Adverse drug reactions due to antipsychotics and sedative-hypnotics in the elderly. J Geriatr Ment Health. 2015;2:16\u201329.","journal-title":"J Geriatr Ment Health"},{"issue":"3","key":"4398_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/0253-7176.207332","volume":"39","author":"S Chawla","year":"2017","unstructured":"Chawla S, Kumar S. Adverse drug reactions and their impact on quality of life in patients on antipsychotic therapy at a tertiary care center in Delhi. Indian J Psychol Med. 2017;39(3):293\u20138. https:\/\/doi.org\/10.4103\/0253-7176.207332 .","journal-title":"Indian J Psychol Med"},{"issue":"3","key":"4398_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4103\/0253-7176.207328","volume":"39","author":"T Gummadi","year":"2017","unstructured":"Gummadi T, Harave VS, Aiyar LN, RajaLekshmi SG, Kunnavil R. Adverse drug reaction monitoring in a tertiary care psychiatry setting: a comparative study between inpatients and outpatients. Indian J Psychol Med. 2017;39(3):306\u201311. https:\/\/doi.org\/10.4103\/0253-7176.207328 .","journal-title":"Indian J Psychol Med"},{"key":"4398_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.18203\/2319-2003.ijbcp20161558","volume":"5","author":"MT Viswanathan","year":"2016","unstructured":"Viswanathan MT, Sisupalan A, Karunakaran V. Pattern of adverse reactions of antipsychotics in a tertiary care hospital. Int J Basic Clin Pharmacol. 2016;5:991\u20138.","journal-title":"Int J Basic Clin Pharmacol"},{"key":"4398_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/jphi.JPHI_46_18","volume":"8","author":"HA Aburamadan","year":"2018","unstructured":"Aburamadan HA, Sridhar SB, Tadross TM. Intensive monitoring of adverse drug reactions to antipsychotic medications in the inpatient psychiatry department of a secondary care hospital of UAE. Int J Pharm Invest. 2018;8:151\u20136.","journal-title":"Int J Pharm Invest"},{"issue":"4","key":"4398_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/0897190014566313","volume":"29","author":"G Hale","year":"2016","unstructured":"Hale G, Kane-Gill M, Groetzinger SL, Smithburger PL. An evaluation of adverse drug reactions associated with antipsychotic use for the treatment of delirium in the intensive care unit. J Pharm Pract. 2016;29(4):355\u201360. https:\/\/doi.org\/10.1177\/0897190014566313 .","journal-title":"J Pharm Pract"},{"issue":"8","key":"4398_CR17","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/j.clinthera.2017.05.173","volume":"39","author":"FKH S\u00f8rup","year":"2017","unstructured":"S\u00f8rup FKH, et al. Adverse drug events with antipsychotics\u2014a sex difference. Clin Ther. 2017;39(8):e56.","journal-title":"Clin Ther"},{"issue":"6","key":"4398_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1017\/S1461145712001277","volume":"16","author":"JP Zhang","year":"2013","unstructured":"Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM, Correll CU. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(6):1205\u201318. https:\/\/doi.org\/10.1017\/S1461145712001277 .","journal-title":"Int J Neuropsychopharmacol"},{"key":"4398_CR19","unstructured":"Udedi M. Improving access to mental health services in Malawi. Ministry of Health Policy Brief. 2016. https:\/\/www.afidep.org\/download\/research-briefs\/policy-briefs\/Improving-access-to-mental-health-services-in-Malawi.pdf . Accessed 12 Aug 2018."},{"key":"4398_CR20","unstructured":"Katayi EO. Impact of side effects of antipsychotics on attitude and adherence to treatment among adult psychiatric outpatients at Mathari Hospital in Kenya. Masters Thesis. School of Pharmacy, University of Nairobi; 2014."},{"issue":"3","key":"4398_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0269881107087976","volume":"22","author":"L Waddell","year":"2008","unstructured":"Waddell L, Taylor M. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. J Psychopharmacol. 2008;22(3):238\u201343.","journal-title":"J Psychopharmacol"},{"key":"4398_CR22","unstructured":"Abou-Setta AM, Mousavi SS, Spooner C, Schouten JR, Pasichnyk D, Armijo-Olivo S, Beaith A, Seida JC, Dursun S, Newton AS, Hartling L. AHRQ Publication No. 12-EHC054-EF. 2012. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK107254\/pdf\/Bookshelf_NBK107254.pdf . Accessed 10 May 2019."},{"issue":"1","key":"4398_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12888-018-1999-x","volume":"19","author":"YS Wubeshet","year":"2019","unstructured":"Wubeshet YS, Mohammed OS, Desse TA. Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel Mental Specialized Hospital, central Ethiopia: cross-sectional study. BMC Psychiatry. 2019;19(1):32. https:\/\/doi.org\/10.1186\/s12888-018-1999-x .","journal-title":"BMC Psychiatry"},{"issue":"5","key":"4398_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40258-015-0176-3","volume":"13","author":"SJ Lubinga","year":"2015","unstructured":"Lubinga SJ, Mutamba BB, Nganizi A, Babigumira JB. A cost-effectiveness analysis of antipsychotics for treatment of schizophrenia in Uganda. Appl Health Econ Health Policy. 2015;13(5):493\u2013506. https:\/\/doi.org\/10.1007\/s40258-015-0176-3 .","journal-title":"Appl Health Econ Health Policy"},{"issue":"9","key":"4398_CR25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/501454","volume":"42","author":"A Thompson","year":"2006","unstructured":"Thompson A, Silverman B, Dzeng L, Treisman G. Psychotropic medications and HIV. Clin Infect Dis. 2006;42(9):1305\u201310. https:\/\/doi.org\/10.1086\/501454 .","journal-title":"Clin Infect Dis"},{"key":"4398_CR26","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1016\/j.eurpsy.2016.01.271","volume":"33","author":"P Mu\u00f1oz-Calero","year":"2016","unstructured":"Mu\u00f1oz-Calero P, S\u00e1nchez FG, Criado NR, Arag\u00f3n RM, Fourcade JFC, Herrero SB, S\u00e1nchez BS. Use of antipsychotics and antidepressants in patients with HIV. Eur Psychiatry. 2016;33:S150\u20131.","journal-title":"Eur Psychiatry"},{"issue":"4","key":"4398_CR27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5530\/ijpcs.5.4.5","volume":"5","author":"S Munoli","year":"2017","unstructured":"Munoli S, Patil SB. Adverse drug reaction monitoring of antipsychotic drugs and mood stabilizers in a teaching hospital. Int J Pharmacol Clin Sci. 2017;5(4):118\u201321.","journal-title":"Int J Pharmacol Clin Sci"},{"key":"4398_CR28","unstructured":"Florida EG, Florida YG, Florida MS. Management of hyponatremia: focus on psychiatric patients. 2013. https:\/\/www.uspharmacist.com\/article\/management-of-hyponatremia . Accessed 19th Apr 2018"},{"issue":"2","key":"4398_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/11319070-000000000-00000","volume":"33","author":"D Meulendijks","year":"2010","unstructured":"Meulendijks D, Mannesse CK, Jansen PAF, Marum RJ, Egberts TCG. Antipsychotic-induced hyponatraemia. Drug Saf. 2010;33(2):101\u201314.","journal-title":"Drug Saf"},{"key":"4398_CR30","volume-title":"Basic & clinical pharmacology","author":"BG Katzung","year":"2012","unstructured":"Katzung BG. Basic & clinical pharmacology. New York: McGraw-Hill Medical; 2012."},{"key":"4398_CR31","unstructured":"Busti AJ. The mechanism for Risperidone (Risperdal) induced hyponatremia in some patients being treated for schizophrenia. 2015. https:\/\/www.ebmconsult.com\/articles\/atypical-antipsychotic-risperidone-risperdal-hyponatremia-schizophrenia . Accessed 19th Apr 2018."},{"issue":"1","key":"4398_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/10673220801924308","volume":"16","author":"AJ Siegel","year":"2008","unstructured":"Siegel AJ. Hyponatremia in psychiatric patients: update on evaluation and management. Harvard Rev Psychiatry. 2008;16(1):13\u201324.","journal-title":"Harvard Rev Psychiatry"},{"key":"4398_CR33","first-page":"1472","volume":"4","author":"KS Silpa","year":"2015","unstructured":"Silpa KS, Aparna S, Pradeep P, Krishna NM. Drug safety evaluation of anti-psychotics in schizophrenia: a prospective observational study in a tertiary care hospital. World J Pharm Res. 2015;4:1472\u201381.","journal-title":"World J Pharm Res"},{"issue":"1","key":"4398_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4088\/JCP.07r03982","volume":"70","author":"C Saavedra-Velez","year":"2009","unstructured":"Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review. J Clin Psychiatry. 2009;70(1):104\u201312.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"4398_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","volume":"125","author":"GP Reynolds","year":"2010","unstructured":"Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treatment\u2014pharmacological mechanisms. Pharmacol Ther. 2010;125(1):169\u201379.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"4398_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5534\/wjmh.2012.30.3.153","volume":"30","author":"YW Park","year":"2012","unstructured":"Park YW, Kim Y, Lee JH. Antipsychotic-induced sexual dysfunction and its management. World J Men\u2019s Health. 2012;30(3):153.","journal-title":"World J Men\u2019s Health"},{"issue":"11","key":"4398_CR37","first-page":"CD003546","volume":"14","author":"HM Schmidt","year":"2012","unstructured":"Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM. Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev. 2012;14(11):CD003546.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"4398_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1590\/S1516-31802006000500012","volume":"124","author":"AMN Costa","year":"2006","unstructured":"Costa AMN, Lima MS, de Mari J. A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia. Sao Paulo Med J. 2006;124(5):291\u20137.","journal-title":"Sao Paulo Med J"},{"issue":"87","key":"4398_CR39","first-page":"113","volume":"16","author":"E Murphy","year":"2013","unstructured":"Murphy E, MacMahon FJ. Pharmacogenetics of antidepressants, mood stabilizers and antipsychotics in diverse human populations. Discov Med. 2013;16(87):113\u201322.","journal-title":"Discov Med"},{"issue":"8","key":"4398_CR40","doi-asserted-by":"publisher","first-page":"P717","DOI":"10.1016\/S2215-0366(16)00085-7","volume":"3","author":"G Gr\u00fcnder","year":"2016","unstructured":"Gr\u00fcnder G, Heinze M, Cordes J, M\u00fchlbauer B, Juckel G, Schulz C, et al. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomized study. Lancet Psychiatry. 2016;3(8):P717\u201329. https:\/\/doi.org\/10.1016\/S2215-0366(16)00085-7 .","journal-title":"Lancet Psychiatry"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4398-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-019-4398-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4398-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:11:44Z","timestamp":1694988704000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-019-4398-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4398"],"URL":"https:\/\/doi.org\/10.1186\/s13104-019-4398-6","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"19 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study ethical approval was granted by the College of Medicine Research and Ethics Committee (COMREC) (Reference Number: SP.2017\/PHARM4\/15). Permission was also sought from the Zomba Mental Hospital management before the study. Written informed consents were obtained from the eligible patients and number codes (serial numbers) were used in identifying each patient participant, to respect patient\u2019s privacy and confidentiality.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"376"}}